About this trial
The study might come up with valuable findings to address poor treatment outcome, poor quality of life, disability score and depressive symptoms. The findings may also be decreased health professional workload. The findings would be supportive evidences for policy makers, program managers, to clinician as well as the patients themselves and for other researchers. The study may help to promote and maintain good treatment outcome for the patients in the study area as well as the country. The findings will also be used for teaching \& learning purposes in educational \& training programs.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults with new drug-susceptible pulmonary TB who will be diagnosed in bacteriological diagnostic methods
not participating in similar study,
mentally capable to provide consent,
physically capable of following the intervention.
Disqualifiers
Seriously ill patients at the time of screening or enrollment
Tuberculosis patients with a known plan to be transferred out of the study sites
Trial design
Single group
Treatments tested in this trial
peer-led education
Combination productThe Intervention is a structured, evidence-based program designed to promote positive and sustained behavioral changes among participants through education, counseling, and supportive follow-up
Treatment groups
Trial outcomes
Primary outcomes
treatment success rate
as defined by 7th edition of Ethiopian guidelines for clinical and programmatic management of TB, TB/HIV, DR-TB and Leprosy and by WHO. Data on the patients' status on the primary outcome variable will be extracted from TB register logbook.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.